1. Home
  2. ADXN vs PRSO Comparison

ADXN vs PRSO Comparison

Compare ADXN & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

N/A

Current Price

$7.00

Market Cap

8.0M

Sector

Health Care

ML Signal

N/A

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$1.02

Market Cap

7.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADXN
PRSO
Founded
2002
2008
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
7.8M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
ADXN
PRSO
Price
$7.00
$1.02
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
4.5K
1.9M
Earning Date
04-27-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
81.23
EPS
N/A
N/A
Revenue
N/A
$14,573,000.00
Revenue This Year
$86.57
$18.48
Revenue Next Year
N/A
$53.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.99
52 Week Low
$5.41
$0.60
52 Week High
$12.05
$2.37

Technical Indicators

Market Signals
Indicator
ADXN
PRSO
Relative Strength Index (RSI) 49.63 46.21
Support Level $5.57 $0.95
Resistance Level $8.60 $1.05
Average True Range (ATR) 0.59 0.08
MACD 0.10 -0.02
Stochastic Oscillator 59.80 34.55

Price Performance

Historical Comparison
ADXN
PRSO

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

Share on Social Networks: